Amy Reeves
Plus aucun poste en cours
Fortune : 2 123 $ au 30/04/2024
Profil
Amy S.
Reeves worked as the Global Controller at Wright Medical Group NV from 2019 to 2021.
She then became the Chief Financial Officer at View, Inc. in 2021, where she will work until 2024.
Reeves received both undergraduate and graduate degrees from the University of Mississippi.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VIEW INC. CLASS A
0,33% | 08/01/2024 | 13 270 ( 0,33% ) | 2 123 $ | 30/04/2024 |
Anciens postes connus de Amy Reeves
| Sociétés | Poste | Fin |
|---|---|---|
| VIEW OPERATING CORPORATION | Directeur Financier/CFO | 02/02/2024 |
| WRIGHT MEDICAL GROUP N.V. | Comptroller/Controller/Auditor | 01/06/2021 |
Formation de Amy Reeves
| University of Mississippi | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIEW OPERATING CORPORATION | Process Industries |
| Entreprise privées | 1 |
|---|---|
Wright Medical Group NV
 Wright Medical Group NV Medical SpecialtiesHealth Technology Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
